670
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Apparent mineralcorticoid excess syndrome, an often forgotten or unrecognized cause of hypokalemia and hypertension: Case report and appraisal of the pathophysiology

, &
Pages 189-192 | Received 03 May 2013, Accepted 30 Jul 2013, Published online: 23 Sep 2013

References

  • Palermo M, Quinkler M, Stewart PM. Apparent mineralocorticoid excess syndrome: An overview. Arq Bras Endocrinol Metabol. 2004;48:687–696.
  • Mantero F, Palermo M, Petrelli MD, Tedde R, Stewart PM, Shackleton CHL. Apparent mineralocorticoid excess: Type I and type II. Steroids. 1996;61:193–196.
  • Stewart PM. Mineralocorticoid hypertension. Lancet. 1999; 353:1341–1347.
  • Melander O. Genetic factor in hypertension – What is known and what does it mean?. Blood Press. 2001;10:254–270.
  • Giebisch GH, Wang WH. Potassium transport – An update. J Nephrol. 2010;23 (Suppl 16):S97–104.
  • Armanini D, Lewicka S, Pratesi C, Scali M, Zennaro M, Zovato S, et al. Further studies on the mechanism of the mineralocorticoid action of licorice in humans. J Endocrinol Invest. 1996;19:624–629.
  • Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 1994; 105:R11–R17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.